Shinhan Capital
Seoul, South Korea
174
6M
145
5.27
3
0.16
1
- Areas of investment
Summary
Shinhan Capital is the famous VC, which was founded in 1991. The venture was found in Asia in South Korea. The main office of represented VC is situated in the Seoul.
When the investment is from Shinhan Capital the average startup value is 5-10 millions dollars. The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are FinTech, EdTech. Among the most popular portfolio startups of the fund, we may highlight True Balance, Mesh Korea, Vedanta Biosciences. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Shinhan Capital, startups are often financed by Shinhan Bank, Yellow Financial Group, Softbank Ventures Asia. The meaningful sponsors for the fund in investment in the same round are KB Investment, Hanwha Investment Corp, Symbiosis. In the next rounds fund is usually obtained by Murex Partners, KB Investment, Bass Investment.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 174
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 5.27
- Follow on index
- 0.16
- Investments by industry
- Information Technology (33)
- Software (31)
- Apps (19)
- Artificial Intelligence (17)
- E-Commerce (17) Show 186 more
- Investments by region
-
- South Korea (142)
- United States (15)
- Iceland (1)
- India (2)
- Japan (2) Show 4 more
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 22M
- Group Appearance index
- 0.95
- Avg. company exit year
- 13
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Avelos Therapeutics | 02 May 2024 | Biotechnology, Life Science | Early Stage Venture | 14M | Seoul, Seoul-t'ukpyolsi, South Korea |
| Lemonbase | 14 Jan 2021 | Publishing, Information Technology, Content | Seed | 5M | New South Wales, Sydney, Australia |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.